The import of streptomycins to Canada sees a significant downward trend from 2024, starting at 591.21 thousand USD and projected to decline to 200.12 thousand USD by 2028. For context, the actual import value in 2023 was 691.82 thousand USD. The year-on-year percentage change shows consistent decreases, signaling a growing reduction in demand or substitution by alternative treatments. The compound annual growth rate (CAGR) over this forecasted period reflects a clear negative trend.

Future trends to watch include:

Potential shifts towards alternative antibiotics or new technologies reducing reliance on streptomycins.
Regulatory and trade policy changes that may influence import costs and demand.
Healthcare policy shifts affecting antibiotic prescriptions.